Srnnews
Published November 16, 2026 · Updated November 17, 2026
J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion - SRN News
Read the full story at Srnnews
More Health Headlines. Lilly to buy Calytrix Bio for up to $1.5 billion · Helus Pharma's psychedelic depression drug succeeds in late-stage study,.
Surfaced by this Google Alert
- Psychedelic biotech